IL6 and COVID-19: Although the underlying pathophysiology of COVID-19 is extremely versatile [10,11], previous studies reported that critically ill patients had higher plasma concentrations of proinflammatory cytokines such as interleukin (IL)-6, IL-10, granulocyte colony stimulating factor, tumor necrosis factor amongst others [12].